Rapidly dividing tumor cells

"Rapidly dividing tumor cells" is not the name of a specific molecular target, receptor, enzyme, or protein. Instead, it is a general descriptive term referring to any population of cancerous or neoplastic cells that are characterized by an abnormally high rate of cell division and proliferation. These rapidly dividing populations are a hallmark of many cancers and are often contrasted with normal somatic cells that divide at much slower rates[2][3]. Therapeutic strategies in oncology frequently aim to exploit this difference in proliferation rate between malignant and healthy tissues. For example, some chemotherapeutic agents non-selectively target all rapidly proliferating cells by interfering with DNA synthesis or mitosis; however, this can also harm healthy tissues with high turnover rates such as bone marrow and gastrointestinal epithelium[3]. More selective approaches may involve identifying molecular dependencies unique to certain rapidly dividing cancer cell subtypes—such as overexpression of proteins like TRIM37 in breast cancer—which can then be targeted by specific inhibitors like PLK4 inhibitors[1]. Because "Rapidly dividing tumor cells" does not refer to one defined molecule but rather describes a cellular phenotype common across many cancers—and because it lacks specificity regarding molecular identity—it cannot be classified under standard categories such as "receptor," "enzyme," etc., nor does it have canonical abbreviations or aliases used in the context of drug targeting. In summary: The term "rapidly dividing tumor cell" refers broadly to any cancer cell population exhibiting increased rates of division due to dysregulation of oncogenes (e.g., Ras, Myc) and/or loss-of-function mutations in tumor suppressors (e.g., p53), leading to unchecked growth characteristic of malignancy[2][3]. While drugs may be designed to preferentially affect these populations based on their proliferative status or unique genetic dependencies[1], the term itself is not suitable as a canonical therapeutic target. If you need structured information about *specific* molecules commonly found in rapidly dividing tumor cells—such as mitotic kinases, cyclin-dependent kinases, PLK4 kinase—or about particular pathways driving rapid division (e.g., Ras/MAPK pathway), please specify those targets individually.

Other names

Rapidly dividing cancer cellsProliferating tumor cellsFast-growing tumor cells